Back
Nektar Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
69
NKTR
Nektar Therapeutics
Last Price:
$72.29
Seasonality Move:
-2.24%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NKTR is experiencing slight buying pressure.
Nektar Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 65.33 | Buy |
| 20-day SMA: | 48.32 | Buy |
| 50-day SMA: | 46.03 | Buy |
| 200-day SMA: | 38.26 | Buy |
| 8-day EMA: | 65.54 | Buy |
| 20-day EMA: | 54.34 | Buy |
| 50-day EMA: | 49.27 | Buy |
| 200-day EMA: | 40.64 | Buy |
Nektar Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.39 | Buy |
| Relative Strength Index (14 RSI): | 81.95 | Buy |
| Chaikin Money Flow: | 322794 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.99 - 60.91) | Buy |
| Bollinger Bands (100): | (41.91 - 62.81) | Buy |
Nektar Therapeutics Technical Analysis
| Feb 5 | Feb 6 | Feb 9 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 17 | Feb 18 | Feb 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Nektar Therapeutics Stock
Is Nektar Therapeutics Stock a Buy?
-
Nektar Therapeutics share price is 73.86 while NKTR 8-day simple moving average is 65.33, which is a Buy signal.
-
The stock price of NKTR is 73.86 while Nektar Therapeutics 20-day SMA is 48.32, which makes it a Buy.
-
Nektar Therapeutics 50-day simple moving average is 46.03 while NKTR share price is 73.86, making it a Buy technically.
-
NKTR stock price is 73.86 and Nektar Therapeutics 200-day simple moving average is 38.26, creating a Buy signal.
NKTR Technical Analysis vs Fundamental Analysis
Buy
69
Nektar Therapeutics (NKTR)
is a Buy
Is Nektar Therapeutics a Buy or a Sell?
-
Nektar Therapeutics stock is rated a BuyThe current Nektar Therapeutics [NKTR] share price is $73.86. The Score for NKTR is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
Nektar Therapeutics Stock Info
Market Cap:
1.3B
Price in USD:
73.86
Share Volume:
868.2K
Nektar Therapeutics 52-Week Range
52-Week High:
74.89
52-Week Low:
6.48
Buy
69
Nektar Therapeutics (NKTR)
is a Buy
Nektar Therapeutics Share Price Forecast
-
What is the Nektar Therapeutics stock price today?The Nektar Therapeutics stock price is 73.86 USD today.
-
Will NKTR stock go up or go down?Nektar Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Nektar Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Nektar Therapeutics is not overvalued.
Is Nektar Therapeutics Stock a Buy?
-
Nektar Therapeutics share price is 73.86 while NKTR 8-day exponential moving average is 65.54, which is a Buy signal.
-
The stock price of NKTR is 73.86 while Nektar Therapeutics 20-day EMA is 54.34, which makes it a Buy.
-
Nektar Therapeutics 50-day exponential moving average is 49.27 while NKTR share price is 73.86, making it a Buy technically.
-
NKTR stock price is 73.86 and Nektar Therapeutics 200-day simple moving average is 40.64, creating a Buy signal.
Fundamental Analysis of Nektar Therapeutics
Is Nektar Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.08 per share, and a decrease next year of $2.48 per share.
Technical Analysis of Nektar Therapeutics
Should I short Nektar Therapeutics stock?
-
NKTR Moving Average Covergence Divergence (MACD) indicator is 8.39, suggesting Nektar Therapeutics is a Buy
-
Nektar Therapeutics Relative Strength Index (RSI) is 81.95, which suggest Nektar Therapeutics is overbought
-
The Bollinger Bands (25) for Nektar Therapeutics is (30.99 - 60.91), which suggest Nektar Therapeutics is a Buy
-
The Bollinger Bands (100) for Nektar Therapeutics is (41.91 - 62.81), which suggest Nektar Therapeutics is a Buy
* Nektar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.